Stocks›Healthcare
WatchAlert

GENNEX LABORATORIES LTD.

GENNEX · BSE · Healthcare · As of 8 Nov 2026
₹9.11
+₹0.11 (+1.22%)(1D)
₹7.0552 Week Range₹16.30
Market Cap
₹242.70 Cr
P/E (Sector)
12.0 (32.3)
P/B Ratio
—
Dividend Yield
—
ROE
61.7%
Debt / Equity
—
Anvest Score
61/100
  • Valuation
    37
  • Quality
    100
  • Growth
    41
  • Health
    78
  • Momentum
    33
Loading company profile…

Fundamentals

P/E Ratio (TTM)
11.99
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹0.76
Market Cap
₹242.70 Cr
ROE
61.71%
ROCE
81.98%
Profit Margin
11.59%
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

GENNEX LABORATORIES LTD. FAQs

3 topics
Expand
What does the GENNEX LABORATORIES LTD. (GENNEX) stock page cover?
GENNEX LABORATORIES LTD. on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for GENNEX?
GENNEX LABORATORIES LTD. is currently shown with a delayed price near ₹9.11, P/E 11.99, and ROE 61.71%.
Does the GENNEX page provide investment advice?
No. The GENNEX page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights